Taysha Gene Therapies Inc (TSHA) financials · rev $9.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Taysha Gene Therapies Inc (TSHA) rev $9.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $9.77M | $8.33M |
| Operating Income | -$110.5M | -$91.5M |
| Net Income | -$109.0M | -$89.3M |
| EPS (Diluted) | -$0.34 | -$0.36 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $343.3M | $160.4M |
| Current Assets | $324.6M | $142.1M |
| Cash & Equivalents | $319.8M | $139.0M |
| PP&E | $6.74M | $7.49M |
| Total Liabilities | $96.4M | $88.8M |
| Current Liabilities | $26.6M | $26.2M |
| Long-term Debt | $50.1M | $43.9M |
| Total Debt | $50.1M† | $43.9M† |
| Shareholders' Equity | $246.9M | $71.5M |
| Retained Earnings | -$711.3M | -$602.3M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$93.1M | -$81.2M |
| CapEx | $738.0K | $374.0K |
| Investing Cash Flow | -$604.0K | -$363.0K |
| Financing Cash Flow | $274.6M | $76.7M |
| Net Change in Cash | $180.9M | -$4.90M |
| Free Cash Flow | -$93.8M | -$81.6M |
FAQ
What is TSHA P/E and revenue?
Taysha Gene Therapies Inc (TSHA) rev $9.8M.
What is TSHA revenue?
Taysha Gene Therapies Inc last cached revenue is $9.77M (FY2025).
Is TSHA profitable?
Taysha Gene Therapies Inc last cached net income is -$109.0M (FY2025).
What are TSHA total assets?
Taysha Gene Therapies Inc last cached total assets are $343.3M (FY2025).
What is TSHA free cash flow?
Taysha Gene Therapies Inc last cached free cash flow is -$93.8M (FY2025).
Not investment advice. Cached statements, not a live tape.